Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $3.34B.
ENTERPRISE VALUE (EV)
$3.34B
Pulse Biosciences, Inc.
Market Cap
$3.42B
Enterprise Value (EV)
$3.34B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Pulse Biosciences, Inc. (PLSE) | $3.42B | $3.34B |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.41B | $3.09B |
| CareDx, Inc (CDNA)vs › | $3.40B | $3.04B |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.34B | $2.30B |
| Celcuity Inc. (CELC)vs › | $3.50B | $4.07B |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.51B | $3.26B |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.53B | $3.53B |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.54B | $4.02B |
| Denali Therapeutics Inc. (DNLI)vs › | $3.11B | $2.94B |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.05B | $3.13B |
Market Cap
$3.42B
Total Debt
$1.57M
Cash
$80.73M
Enterprise Value
$3.34B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
